Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Anticancer Research|December 1, 2010
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studiesLaura Bonmassar, Emanuela Fossile, Alessandro Scoppola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 13, 2024
Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real lifeMichele Reni, Guido Giordano, Marco Audisio, et al.
Oncology|December 4, 2025
Clinicomics for predicting HER2 expression in metastatic colorectal cancer: a multicenter machine learning analysis on real-world dataVincenzo Formica, Cristina Morelli, Michela Rofei, et al.
Oncology|September 12, 2023
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with HistologyCaterina Vivaldi, Virginia Genovesi, Clara Ugolini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitroPierpaolo Correale, Maria Grazia Cusi, Maria Teresa Del Vecchio, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 13, 2025
Peripheral Thyroid Hormones, Inflammatory and Skeletal Muscle Indexes in Advanced Cervical Cancer Treated With CemiplimabValentina Tuninetti, Elisa Virano, Amedeo Calvo, et al.
The Oncologist|October 9, 2015
Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New HopeFilippo Pietrantonio, Chiara Cremolini, Giuseppe Aprile, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2023
Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LVFilippo Pietrantonio, Francesca Bergamo, Daniele Rossini, et al.
Cancers|April 27, 2024
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint InhibitorsSara Mokbel, Giuilia Baciarello, Pernelle Lavaud, et al.
BMC Cancer|October 9, 2021
Results of the observational prospective RealFLOT studyElisa Giommoni, Daniele Lavacchi, Giuseppe Tirino, et al.
Pageof 9